PD-1, a new target for sepsis treatment: Better late than never

Journal of Leukocyte Biology

Volumn 88, Issue 2, 2010, Pages 225-226

  Goyert, Sanna M ^a   Silver, Jack ^a  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Host pathogen interactions; Immunosuppression; Septic shock sepsis

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8A; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 7; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; APOPTOSIS REGULATORY PROTEIN; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN;

APOPTOSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; MORBIDITY; MORTALITY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; HOST PATHOGEN INTERACTION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; SEPTIC SHOCK;

ANTIBODIES; ANTIGENS, CD; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; DRUG DELIVERY SYSTEMS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOSUPPRESSION; SEPSIS; SHOCK, SEPTIC;

EID: 77956419602     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0410240     Document Type: Note

References (20)

1. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., Pinsky, M. R. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29, 1303-1310. (Pubitemid 32641789)
2. Martin, G. S., Mannino, D. M., Eaton, S., Moss, M. (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554. (Pubitemid 36437931)
3. Russell, J. A. (2006) Management of sepsis. N. Engl. J. Med. 355, 1699-1713.
4. Marti-Carvajal, A., Salanti, G., Cardona, A. F. (2008) Human recombinant activated protein C for severe sepsis. Cochrane Database Syst. Rev. CD004388.
5. Osuchowski, M. F., Welch, K., Siddiqui, J., Remick, D. G. (2006) Circulating cytokine/ inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177, 1967-1974. (Pubitemid 44092537)
6. Osuchowski, M. F., Welch, K., Yang, H., Siddiqui, J., Remick, D. G. (2007) Chronic sepsis mortality characterized by an individualized inflammatory response. J. Immunol. 179, 623-630. (Pubitemid 46986580)
7. Wang, T. S., Deng, J. C. (2008) Molecular and cellular aspects of sepsis-induced immunosuppression. J. Mol. Med. 86, 495-506.
8. Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M. R., Delwart, E., Sepulveda, H., Balderas, R. S., Routy, J. P., Haddad, E. K., Sekaly, R. P. (2006) Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12, 1198-1202.
9. Zouali, M., Sarmay, G. (2004) B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment. Arthritis Rheum. 50, 2730-2741. (Pubitemid 39209509)
10. Sharpe, A. H., Wherry, E. J., Ahmed, R., Freeman, G. J. (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8, 239-245. (Pubitemid 46745373)
11. Huang, X., Venet, F., Wang, Y. L., Lepape, A., Yuan, Z., Chen, Y., Swan, R., Kherouf, H., Monneret, G., Chung, C. S., Ayala, A. (2009) PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci. USA 106, 6303-6308.
12. Brahmamdam, P., Inoue, S., Unsinger, J., Chang, K. D., McDunn, J. E., Hotchkiss, R. S. (2010) Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis. J. Leukoc. Biol. 88, 233-240.
13. Unsinger, J., McGlynn, M., Kasten, K. R., Hoekzema, A. S., Watanabe, E., Muenzer, J. T., McDonough, J. S., Tschoep, J., Ferguson, T. A., McDunn, J. E., Morre, M., Hildeman, D. A., Caldwell, C. C., Hotchkiss, R. S. (2010) IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J. Immunol. 184, 3768-3779.
14. Inoue, S., Unsinger, J., Davis, C. G., Muenzer, J. T., Ferguson, T. A., Chang, K., Osborne, D. F., Clark, A. T., Coopersmith, C. M., McDunn, J. E., Hotchkiss, R. S. (2010) IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J. Immunol. 184, 1401-1409.
15. Plitas, G., Burt, B. M., Nguyen, H. M., Bamboat, Z. M., DeMatteo, R. P. (2008) Toll-like receptor 9 inhibition reduces mortality in polymicrobial sepsis. J. Exp. Med. 205, 1277-1283. (Pubitemid 351831485)
16. Pinheiro da Silva, F., Aloulou, M., Skurnik, D., Benhamou, M., Andremont, A., Velasco, I. T., Chiamolera, M., Verbeek, J. S., Launay, P., Monteiro, R. C. (2007) CD16 promotes Escherichia coli sepsis through an FcR γ inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nat. Med. 13, 1368-1374. (Pubitemid 350073597)
17. Nguyen, Q. T., Ju, S. A., Park, S. M., Lee, S. C., Yagita, H., Lee, I. H., Kim, B. S. (2009) Blockade of CD137 signaling counteracts polymicrobial sepsis induced by cecal ligation and puncture. Infect. Immun. 77, 3932-3938.
18. Peña, G., Cai, B., Deitch, E.A., Ulloa, L. (2010) JAK2 inhibition prevents innate immune responses and rescues animals from sepsis. J. Mol. Med., Epub ahead of print.
19. Csoka, B., Nemeth, Z. H., Mukhopadhyay, P., Spolarics, Z., Rajesh, M., Federici, S., Deitch, E. A., Batkai, S., Pacher, P., Hasko, G. (2009) CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis. PLoS One 4, e6409.
20. Lee, S. C., Ju, S. A., Pack, H. N., Heo, S. K., Suh, J. H., Park, S. M., Choi, B. K., Kwon, B. S., Kim, B. S. (2005) 4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection. Infect. Immun. 73, 5144-5151.